Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.

< BACK TO ARCHIVE


2022 Dec 27


Clin Neuropharmacol


http://www.ncbi.nlm.nih.gov/pubmed/36728838?dopt=Abstract

Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.

Authors

Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.
Gonul Oner O, Gudek H C, Erturk Cetin O, Demir S
Clin Neuropharmacol. 2022 Dec 27.
PMID: 36728838.

Abstract

Botulinum toxin type A is widely used for the treatment of spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine, and also cosmetic purposes. Therapeutic use is commonly effective and safe. However, if toxin enters the vascular space and gets through to peripheral cholinergic nerve terminals, it may lead to iatrogenic botulism.
Read This Paper